DM
GMAB icon

Deerfield Management’s Genmab GMAB Stock Holding History

Deerfield Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189M Buy
6,865,000
+4,403,000
+179% +$117M 1.97% 12
2026
Q1 		$66.1M Buy
+2,462,000
New +$73.8M 0.78% 39

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Deerfield Management's GMAB Position: Q2 2026 in Review

Deerfield Management increased its Genmab (GMAB) stake by 179% in Q2 2026, buying an estimated $117M and bringing the position to 6,865,000 shares worth $189M. The position accounts for 1.97% of the portfolio, ranked #12.

Deerfield Management first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Deerfield Management held 6,865,000 shares of Genmab worth $189M as of Q2 2026.
  • Deerfield Management bought 4,403,000 Genmab shares in Q2 2026, an estimated $117M.
  • Genmab made up 1.97% of Deerfield Management's portfolio in Q2 2026, its #12 holding.
  • Deerfield Management first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.